After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

In a survey of 2,000 single adults ages 18 to 91 conducted by Indiana University, among those taking GLP-1 drugs to lose ...

GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.

After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...

GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...

There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity ...

Injectable GLP-1 drugs are shot into subcutaneous fat and released slowly into the bloodstream, whereas pills are ingested and must avoid being broken down in the gastrointestinal tract.

People using GLP-1 medications are more likely to suffer severe acid reflux, a new study suggests. Researchers found patients ...

People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...

GLP-1 Drugs: Demand Surges in a Long-Established Market. The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research.